1-7 of 7
Rainer Kimmig
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract P5-04-19: Gene variants in circulating tumor cells as markers of resistance in patients with metastatic breast cancer receiving CDK4/6 inhibitors

Free
Sabine Kasimir-Bauer, Stefanos Moukas, Hans-Christian Kolberg, Mitra Tewes, Markus Storbeck, Peter Hahn, Siegfried Hauch, Oliver Hoffmann, Rainer Kimmig, Corinna Keup
Journal: Clinical Cancer Research
Clin Cancer Res (2025) 31 (12_Supplement): P5-04-19.
https://doi.org/10.1158/1557-3265.SABCS24-P5-04-19
Published: 13 June 2025
View articletitled, Abstract P5-04-19: Gene variants in circulating tumor cells as markers of resistance in patients with metastatic breast cancer receiving CDK4/6 inhibitors
Journal Articles

Bevacizumab May Differentially Improve Prognosis of Advanced Ovarian Cancer Patients with Low Expression of VEGF-A165b, an Antiangiogenic VEGF-A Splice Variant

Available to Purchase
Pauline Wimberger, Mara Julia Gerber, Jacobus Pfisterer, Kati Erdmann, Susanne Füssel, Theresa Link, Andreas du Bois, Stefan Kommoss, Florian Heitz, Jalid Sehouli, Rainer Kimmig, Nikolaus de Gregorio, Barbara Schmalfeldt, Tjoung-Won Park-Simon, Klaus Baumann, Felix Hilpert, Marcel Grube, Willibald Schröder, Alexander Burges, Antje Belau, Lars Hanker, Jan Dominik Kuhlmann
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (21): 4660–4668.
https://doi.org/10.1158/1078-0432.CCR-22-1326
Published: 01 November 2022
View articletitled, Bevacizumab May Differentially Improve Prognosis of Advanced Ovarian Cancer Patients with Low Expression of VEGF-A165b, an Antiangiogenic VEGF-A Splice Variant
Open the PDF for Bevacizumab May Differentially Improve Prognosis of Advanced Ovarian Cancer Patients with Low Expression of VEGF-A165b, an Antiangiogenic VEGF-A Splice Variant in another window
Includes: Supplementary data
Journal Articles

Dilution of Molecular–Pathologic Gene Signatures by Medically Associated Factors Might Prevent Prediction of Resection Status After Debulking Surgery in Patients With Advanced Ovarian Cancer

Available to Purchase
Florian Heitz, Stefan Kommoss, Roshan Tourani, Anthony Grandelis, Locke Uppendahl, Constantin Aliferis, Alexander Burges, Chen Wang, Ulrich Canzler, Jinhua Wang, Antje Belau, Sonia Prader, Lars Hanker, Sisi Ma, Beyhan Ataseven, Felix Hilpert, Stephanie Schneider, Jalid Sehouli, Rainer Kimmig, Christian Kurzeder, Barbara Schmalfeldt, Elena I. Braicu, Philipp Harter, Sean C. Dowdy, Boris J. Winterhoff, Jacobus Pfisterer, Andreas du Bois
Journal: Clinical Cancer Research
Clin Cancer Res (2020) 26 (1): 213–219.
https://doi.org/10.1158/1078-0432.CCR-19-1741
Published: 03 January 2020
View articletitled, Dilution of Molecular–Pathologic Gene Signatures by Medically Associated Factors Might Prevent Prediction of Resection Status After Debulking Surgery in Patients With Advanced Ovarian Cancer
Open the PDF for Dilution of Molecular–Pathologic Gene Signatures by Medically Associated Factors Might Prevent Prediction of Resection Status After Debulking Surgery in Patients With Advanced Ovarian Cancer in another window
Includes: Supplementary data
Journal Articles

Prognostic Value of RANKL/OPG Serum Levels and Disseminated Tumor Cells in Nonmetastatic Breast Cancer

Free
Tilman D. Rachner, Sabine Kasimir-Bauer, Andy Göbel, Kati Erdmann, Oliver Hoffmann, Andrew Browne, Pauline Wimberger, Martina Rauner, Lorenz C. Hofbauer, Rainer Kimmig, Ann-Kathrin Bittner
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (4): 1369–1378.
https://doi.org/10.1158/1078-0432.CCR-18-2482
Published: 15 February 2019
View articletitled, Prognostic Value of RANKL/OPG Serum Levels and Disseminated Tumor Cells in Nonmetastatic Breast Cancer
Open the PDF for Prognostic Value of RANKL/OPG Serum Levels and Disseminated Tumor Cells in Nonmetastatic Breast Cancer in another window
Includes: Supplementary data
Journal Articles

The AA Genotype of the Regulatory BCL2 Promoter Polymorphism (−938C>A) Is Associated with a Favorable Outcome in Lymph Node–Negative Invasive Breast Cancer Patients

Free
Hagen S. Bachmann, Friedrich Otterbach, Rainer Callies, Holger Nückel, Maja Bau, Kurt W. Schmid, Winfried Siffert, Rainer Kimmig
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (19): 5790–5797.
https://doi.org/10.1158/1078-0432.CCR-06-2673
Published: 01 October 2007
View articletitled, The AA Genotype of the Regulatory BCL2 Promoter Polymorphism (−938C>A) Is Associated with a Favorable Outcome in Lymph Node–Negative Invasive Breast Cancer Patients
Open the PDF for The AA Genotype of the Regulatory BCL2 Promoter Polymorphism (−938C>A) Is Associated with a Favorable Outcome in Lymph Node–Negative Invasive Breast Cancer Patients in another window
Journal Articles

Effective Relief of Malignant Ascites in Patients with Advanced Ovarian Cancer by a Trifunctional Anti-EpCAM × Anti-CD3 Antibody: A Phase I/II Study

Free
Alexander Burges, Pauline Wimberger, Carolin Kümper, Vera Gorbounova, Harald Sommer, Barbara Schmalfeldt, Jacobus Pfisterer, Michail Lichinitser, Anatoliy Makhson, Vladimir Moiseyenko, Angelika Lahr, Elisabeth Schulze, Michael Jäger, Michael A. Ströhlein, Markus Maria Heiss, Thomas Gottwald, Horst Lindhofer, Rainer Kimmig
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (13): 3899–3905.
https://doi.org/10.1158/1078-0432.CCR-06-2769
Published: 02 July 2007
View articletitled, Effective Relief of Malignant Ascites in Patients with Advanced Ovarian Cancer by a Trifunctional Anti-EpCAM × Anti-CD3 Antibody: A Phase I/II Study
Open the PDF for Effective Relief of Malignant Ascites in Patients with Advanced Ovarian Cancer by a Trifunctional Anti-EpCAM × Anti-CD3 Antibody: A Phase I/II Study in another window
Journal Articles

Association of Urokinase-Type Plasminogen Activator and Its Inhibitor with Disease Progression and Prognosis in Ovarian Cancer

Free
Gottfried Konecny, Michael Untch, Astrid Pihan, Rainer Kimmig, Martina Gropp, Petra Stieber, Herrmann Hepp, Dennis Slamon, Mark Pegram
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (6): 1743–1749.
Published: 01 June 2001
View articletitled, Association of Urokinase-Type Plasminogen Activator and Its Inhibitor with Disease Progression and Prognosis in Ovarian Cancer
Open the PDF for Association of Urokinase-Type Plasminogen Activator and Its Inhibitor with Disease Progression and Prognosis in Ovarian Cancer in another window